New York State Teachers Retirement System Sells 8,258 Shares of Humana Inc. (NYSE:HUM)

New York State Teachers Retirement System lowered its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 8.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 92,943 shares of the insurance provider's stock after selling 8,258 shares during the period. New York State Teachers Retirement System owned 0.08% of Humana worth $24,593,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HUM. Vanguard Group Inc. increased its position in shares of Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the period. Dodge & Cox grew its position in shares of Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Pzena Investment Management LLC raised its position in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after buying an additional 1,103,132 shares in the last quarter. Geode Capital Management LLC boosted its stake in Humana by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after buying an additional 63,562 shares during the period. Finally, Invesco Ltd. grew its position in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after buying an additional 550,692 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Down 2.1%

Shares of NYSE:HUM traded down $5.22 during midday trading on Friday, hitting $238.58. 960,833 shares of the stock traded hands, compared to its average volume of 1,813,253. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $28.79 billion, a PE ratio of 16.87, a P/E/G ratio of 1.84 and a beta of 0.44. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The business's 50 day moving average is $240.79 and its two-hundred day moving average is $258.69.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same quarter last year, the business posted $7.23 EPS. The business's revenue was up 8.4% on a year-over-year basis. As a group, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is presently 25.04%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research report on Thursday, May 1st. Truist Financial set a $280.00 price objective on shares of Humana and gave the stock a "hold" rating in a report on Tuesday, June 17th. Guggenheim assumed coverage on Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target on the stock. Barclays set a $268.00 price objective on Humana and gave the company an "equal weight" rating in a research report on Thursday, June 12th. Finally, Bank of America dropped their target price on Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research report on Tuesday, June 17th. Sixteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Humana has a consensus rating of "Hold" and an average price target of $280.76.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.